Automated Liquid Handling Platform

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

FDA OFFICE OF ACQ GRANT SVCS

Contract Value

Not provided

Codes & Classification
Solicitation Number

SSN-CBER-2026-135922

NAICS

334516 - Analytical Laboratory Instrument Manufacturing

Classification Code

6640

Additional Details
Set Aside

NONE

Place of Performance

Silver Spring, Maryland, UNITED STATES

SourceSAM
Documents3
The Food and Drug Administration (FDA), under the Department of Health and Human Services, has issued a Sources Sought notice for the acquisition of a newly manufactured Automated Liquid Handling Platform. This procurement is managed by the FDA Office of Acquisition and Grant Services, with the place of performance specified as Silver Spring, Maryland. The primary objective of this procurement is to identify potential sources capable of providing a benchtop automated liquid handling platform that meets stringent technical and operational requirements for laboratory use. The intended outcome is to enhance laboratory efficiency and precision in handling liquid samples, particularly for applications requiring fast, accurate pipetting and serial dilutions in high-throughput formats. Key requirements for the equipment include: - The platform must be newly manufactured, with no used, refurbished, reconditioned, remanufactured, or previously demonstrated components. - It must be user-friendly, easy to operate and clean, and designed to save both space and energy. - The system should support fast automatic pipetting of multiple solutions and serial dilutions across or down microplate wells, accommodating variable liquid volumes. - It must be capable of pipetting into single rows, columns, or individual wells in both 96-well and 384-well formats, with interchangeable well formats based on user needs. - Customizability to laboratory assay requirements is essential, including programmable operating temperatures for use across a range of conditions. - The platform must be operable within a biosafety cabinet with internal dimensions of 46 inches wide, 24 inches deep, and 30 inches high, supporting up to 120 lbs without disrupting airflow, to facilitate handling of sterile or hazardous materials. Minimum technical specifications include: - Benchtop format compatible with biosafety cabinet requirements. - Serial dilution capability using standard disposable tip heads. - Interchangeable 96-channel and 384-channel pipetting heads with independent tip pickup. - Minimum 15-position deck capacity. - Dispensing range from 0.1 to 200 microliters, with accuracy and precision not exceeding 5% deviation. - Configurability for shaking, heating, cooling, and filtration, with the ability to accept these features post-delivery. - Integrated controller and software for custom protocol generation, plus a dedicated computer for machine control. - Compatibility with standard microplates (96-well and 384-well). - Operation under ambient conditions of 5 to 40°C and 10 to 90% relative humidity (non-condensing), with no deck or plate temperature control required. - Compliance with all applicable federal, state, and local safety standards. Based on market research, the FDA has identified the Agilent Technologies Bravo Automated Liquid Handling Platform as the only equipment currently meeting all specified requirements, particularly regarding size, low-volume dispensing, and biosafety cabinet compatibility. The procurement is classified under NAICS code 334516 (Analytical Laboratory Instrument Manufacturing) and Product Service Code 6640. There are no set-aside requirements for this opportunity, making it open to all qualified vendors. Interested parties should note that the notice is currently inactive, with the original posting date of September 9, 2026, and a response deadline of November 9, 2026. For further information or to express interest, contractors may contact Reagan Davis at [email protected] or 301-796-0910. Additional details and attachments are available via the SAM.gov opportunity ID 9372f96573a245608715adcd195f824e. This opportunity is particularly suited for manufacturers and suppliers of advanced laboratory automation equipment who can deliver a solution that meets the FDA’s precise technical and operational requirements, ensuring compliance and reliability throughout the contract lifecycle.